Clinical Trial Update: 3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women [Phase 1]

View source ↗

Summary

This document reports a Phase 1, dose-escalation trial of parathyroid hormone-related protein (PTHrP) in postmenopausal women with osteoporosis that has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• PTHrP (parathyroid hormone-related peptide)

Snippet

Sponsor: University of Pittsburgh | Conditions: Osteoporosis, Osteoporosis, Postmenopausal | Phase 1 | Status: COMPLETED